Hypercupraemia Induced by Antiepileptic Drugs
1 Serum copper and zinc levels were measured in 84 treated male epileptics, aged between 6 and 18 years, by an atomic absorption spectroscopic method. These patients were selected randomly from a residential special school. Twenty drug-free healthy but educationally subnormal (ESN) male subjects of similar age group from the same school acted as controls. 2 No abnormality in serum zinc level was observed. 3 In nineteen (22.6%) epileptics, copper levels were above the upper level of normal range (20.5 μmol/l), whereas this was only marginally elevated (20.8 μmol/l) in one (5%) ESN subject. 4 The mean copper level in all epileptics was higher than the controls ( P<0.01), but there was no difference between the epileptics treated with sodium valproate alone and the ESN group. 5 The patients who were receiving carbamazepine either as monotherapy or in combination with other drugs except phenytoin, had higher mean copper levels than the controls ( P<0.01). A similar observation was made in relation with phenytoin polytherapy (but excluding carbamazepine). 6 There also appeared to be an association between the high serum copper levels and diffuse/generalized electroencephalographic changes ( P < 0.001). Some antiepileptic drugs, particularly carbamazepine, can produce such electroencephalographic abnormalities. 7 It is concluded that hypercupraemia observed in these treated epileptics were related to the induction of caeruloplasmin synthesis by phenytoin and carbamazepine.